<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00102856</url>
  </required_header>
  <id_info>
    <org_study_id>KS-NEUROMOD_01, Stage Ib</org_study_id>
    <secondary_id>IZKF Muenster: Kne3/074/04</secondary_id>
    <nct_id>NCT00102856</nct_id>
  </id_info>
  <brief_title>Neuromodulation and Language Acquisition (Stage Ib)</brief_title>
  <official_title>Neuromodulation and Language Acquisition (KS-Neuromod_01, Stage Ib)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Muenster</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Muenster</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether rivastigmine or pramipexol are effective in
      boosting semantic language acquisition in healthy subjects.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Our prior work shows that d-amphetamine and the dopamine precursor levodopa markedly improve
      word learning success in healthy subjects. In this randomized, placebo-controlled,
      double-blind clinical trial, we probe whether a selective d2/d3 dopamine agonist
      (pramipexole) or cholinergic neuromodulation (rivastigmine), after a titration period of five
      days, will yield a learning enhancement comparable to using levodopa in healthy subjects. The
      expected scientific results will strengthen the basis for transferring neuromodulatory
      interventions from the laboratory to stroke patients with language dysfunctions.
    </textblock>
  </detailed_description>
  <overall_status>Suspended</overall_status>
  <start_date>January 2005</start_date>
  <completion_date>June 2006</completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Boost in language learning success (percent hits) through neuromodulation</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Stability of language learning success after one week, one month, and one year</measure>
  </secondary_outcome>
  <enrollment>60</enrollment>
  <condition>Healthy</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Pramipexole</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Rivastigmine</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy subjects

          -  20-35 years old

          -  Right handedness

          -  Left language dominance (as assessed by functional transcranial Doppler
             ultrasonography [fTCD])

        Exclusion Criteria:

          -  Neurological/psychiatric/metabolic/cardiac disorders

          -  Asthma

          -  Known allergic reactions to one of the experimental drugs

          -  Other drugs affecting the central nervous system

          -  Leisure drug ingestion during the past 4 weeks (urine test)

          -  Smoking cessation during the past 2 weeks

          -  &gt; 6 cups of coffee or energy drinks per day

          -  &gt; 10 cigarettes per day

          -  &gt; 50 grams of alcohol per day
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Caterina Breitenstein, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Dept. of Neurology, University Hospital Muenster</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Stefan Knecht, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Dept. of Neurology, University Hospital Muenster</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Dept. of Neurology, University Hospital Muenster</name>
      <address>
        <city>Muenster</city>
        <state>Nordrhein-Westfalen</state>
        <zip>48129</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <link>
    <url>http://neurologie.uni-muenster.de/cms/front_content.php?idcat=37</url>
    <description>Homepage of Dr. Breitenstein</description>
  </link>
  <reference>
    <citation>Knecht S, Breitenstein C, Bushuven S, Wailke S, Kamping S, Fl√∂el A, Zwitserlood P, Ringelstein EB. Levodopa: faster and better word learning in normal humans. Ann Neurol. 2004 Jul;56(1):20-6.</citation>
    <PMID>15236398</PMID>
  </reference>
  <reference>
    <citation>Breitenstein C, Wailke S, Bushuven S, Kamping S, Zwitserlood P, Ringelstein EB, Knecht S. D-amphetamine boosts language learning independent of its cardiovascular and motor arousing effects. Neuropsychopharmacology. 2004 Sep;29(9):1704-14.</citation>
    <PMID>15114342</PMID>
  </reference>
  <verification_date>September 2006</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 3, 2005</study_first_submitted>
  <study_first_submitted_qc>February 3, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 4, 2005</study_first_posted>
  <last_update_submitted>June 23, 2010</last_update_submitted>
  <last_update_submitted_qc>June 23, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 24, 2010</last_update_posted>
  <keyword>language acquisition</keyword>
  <keyword>plasticity</keyword>
  <keyword>stroke recovery</keyword>
  <keyword>associative learning</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pramipexole</mesh_term>
    <mesh_term>Rivastigmine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

